Agilon Health's (AGL) "Market Perform" Rating Reiterated at Sanford C. Bernstein

Key Points

• Agilon Health's stock rating remains at "market perform" with a revised price target of $1.40, down from a previous target of $4.00, indicating a potential 12.45% upside from its last closing price.
• Citigroup recently upgraded Agilon Health from "neutral" to "buy" with a price target of $5.00, while several other analysts have varied target price adjustments, contributing to an average price target of $3.07.
• The company reported a loss of ($0.25) per share for the previous quarter, missing expectations, and noted a 5.9% decline in revenue year-over-year.

Sanford C. Bernstein restated their market perform rating on shares of Agilon Health (NYSE:AGL - Free Report) in a report published on Wednesday, MarketBeat.com reports. They currently have a $1.40 price objective on the stock, down from their prior price objective of $4.00.

A number of other research firms also recently weighed in on AGL. Citigroup raised shares of Agilon Health from a "neutral" rating to a "buy" rating and boosted their price target for the stock from $3.25 to $5.00 in a research note on Friday, April 25th. Benchmark dropped their price target on shares of Agilon Health from $4.00 to $1.50 and set a "buy" rating for the company in a research note on Wednesday, August 6th. Robert W. Baird dropped their price target on shares of Agilon Health from $5.00 to $1.00 and set a "neutral" rating for the company in a research note on Thursday, August 14th. Barclays lowered their target price on shares of Agilon Health from $3.00 to $1.50 and set an "underweight" rating for the company in a research note on Wednesday, August 6th. Finally, Wells Fargo & Company lowered their target price on shares of Agilon Health from $6.00 to $5.00 and set an "overweight" rating for the company in a research note on Tuesday, May 13th. Four equities research analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, Agilon Health has an average rating of "Hold" and an average target price of $3.07.

Agilon Health Trading Up 5.6%

Shares of AGL traded up $0.0750 on Wednesday, reaching $1.4050. 3,442,565 shares of the company's stock were exchanged, compared to its average volume of 7,217,964. The stock has a market capitalization of $582.26 million, a P/E ratio of -1.82 and a beta of 0.14. The business has a 50 day moving average price of $1.86 and a two-hundred day moving average price of $2.98. Agilon Health has a 12 month low of $0.71 and a 12 month high of $6.08.

Agilon Health (NYSE:AGL - Get Free Report) last posted its quarterly earnings results on Monday, August 4th. The company reported ($0.25) earnings per share for the quarter, missing analysts' consensus estimates of ($0.11) by ($0.14). The business had revenue of $1.39 billion for the quarter, compared to the consensus estimate of $1.47 billion. Agilon Health had a negative return on equity of 66.76% and a negative net margin of 5.35%.The company's quarterly revenue was down 5.9% on a year-over-year basis. During the same period last year, the firm earned ($0.07) earnings per share. Equities research analysts predict that Agilon Health will post -0.59 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in AGL. Millennium Management LLC boosted its holdings in shares of Agilon Health by 187.8% in the fourth quarter. Millennium Management LLC now owns 7,212,525 shares of the company's stock valued at $13,704,000 after buying an additional 4,706,357 shares during the period. Nuveen LLC acquired a new position in shares of Agilon Health in the first quarter valued at approximately $17,242,000. Algert Global LLC boosted its holdings in shares of Agilon Health by 1,042.7% in the fourth quarter. Algert Global LLC now owns 2,108,687 shares of the company's stock valued at $4,007,000 after buying an additional 1,924,157 shares during the period. CenterBook Partners LP acquired a new position in shares of Agilon Health in the first quarter valued at approximately $8,315,000. Finally, Marshall Wace LLP boosted its holdings in shares of Agilon Health by 3,590.4% in the second quarter. Marshall Wace LLP now owns 1,484,114 shares of the company's stock valued at $3,413,000 after buying an additional 1,443,898 shares during the period.

Agilon Health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.